Citation, DOI, disclosures and article data
At the time the article was created Yuranga Weerakkody had no recorded disclosures.View Yuranga Weerakkody's current disclosures
At the time the article was last revised Daniel J Bell had no recorded disclosures.View Daniel J Bell's current disclosures
CA 27-29 is a tumor marker and is a soluble form of glycoprotein MUC1. It may be elevated in patients with breast cancer. Tumors of the colon, stomach, kidney, lung, ovary, pancreas, uterus, and liver may also raise CA 27-29 levels.
- 1. Frenette PS, Thirlwell MP, Trudeau M, Thomson DM, Joseph L, Shuster JS. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies. (1994) Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 15 (5): 247-54. Pubmed
- 2. Kurian S, Khan M, Grant M. CA 27-29 in patients with breast cancer with pulmonary fibrosis. (2008) Clinical breast cancer. 8 (6): 538-40. doi:10.3816/CBC.2008.n.067 - Pubmed
- 3. Beveridge RA. Review of clinical studies of CA 27.29 in breast cancer management. (1999) The International journal of biological markers. 14 (1): 36-9. Pubmed